In this ARC Talks webinar, amyloidosis cardiologist, Dr. Mazen Hanna discusses the function of implantable, electronic devices in cardiac management of amyloidosis patients.
Dr. Hanna provides clarity about which devices exist to assist patients, and the role they serve in heart maintenance. This includes devices for atrial fibrillation management, such as a watchman device, in addition to the indications for a pacemaker or ICD device.
Original Presentation Date:
February 08, 2024
Key Webinar Highlights:
0:00 — Introduction
3:18 — Start of presentation
4:27 — Atrial fibrillation diagram
6:56 — Atrial fibrillation in cardiac amyloidosis
10:02 — Atrial fibrillation: anticoagulation
12:06— Transesophageal echocardiogram (TEE)
13:13 — Intracardiac thrombosis in cardiac amyloidosis
16:08 — CAA occlusion
19:00 — Atrial fibrillation ablation
20:54 — Atrial fibrillation rate control
21:59 — Atrial fibrillation rhythm control
23:06 — Conduction
25:38 — How a pacemaker works
27:57 — Impact of RV pacing on outcomes in ATTR cardiac amyloidosis
28:29 — Cardiac resynchronization therapy in ATTR cardiac amyloidosis
30:17 — Ventricular Arrythmias in cardiac amyloidosis
31:37 — Primary prevention ICD in ATTR cardiac amyloidosis
32:41 — Standard protocol
33:52 — Guidelines for defibrillators
34:37 — MEMs based pressure sensor for monitoring pulmonary artery pressures
36:55 — Presentation summary
38:20 — Start of Q and A session
Contact Us:
Call +1 (617) 467-5170
Email us at arc@arci.org
